Comparison of CD146 Positive and Negative Mesenchymal Stem Cells in Improving Premature Ovarian Failure

    June 2022 in “ Stem Cell Research & Therapy ”
    Lin Zhang, Yang Sun, Xiaoxu Zhang … Lisheng Wang
    Studysummary This study found that umbilical cord-derived CD146+ MSCs showed a stronger ability to improve ovarian function and modulate immune responses in a mouse model of premature ovarian failure compared to CD146- MSCs, though both subpopulations effectively repaired reproductive ability.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on stemcellres.biomedcentral.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia BioMed Research International · 2020
    2. Mesenchymal Stem Cells for Regenerative Medicine Cells · 2019